AETHLON MEDICAL INC
AEMDNasdaq
$0.65
↓ -3.4%Jul 17 close · end-of-day
Price
1Y↓ -94.7%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$436,311.99
Enterprise Value
-$4.6M
P/E
—
P/S
—
P/B
0.1
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$7.2M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-146.4%
ROIC
—
Debt / Equity
—
Net Cash
$5.0M
Return 1Y
-94.9%
Company profile
Aethlon Medical, Inc. focuses on developing products to diagnose and treat life and organ threatening diseases. The company was founded in 1999 and is based in San Diego, California.
- CEO
- Charles J. Fisher
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 10
- Headquarters
- California
- Website
- aethlonmedical.com
Earnings
AEMD Q4 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue——
Diluted EPS-$3.57↓ -93.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
| Revenue | $659,104.00 | $294,165.00 | $574,245.00 | $0.00 | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$7.9M | -$10.4M | -$11.9M | -$12.6M | -$9.3M | -$7.3M |
| Net income | -$7.9M | -$10.4M | -$12.0M | -$12.2M | -$13.4M | -$7.2M |
| Diluted EPS | — | -$0.71 | -$5.86 | -$38.87 | -$85.77 | -$10.61 |
| Operating cash flow | -$6.8M | -$9.8M | -$10.5M | -$10.1M | -$7.6M | -$7.0M |
| Free cash flow | -$6.8M | -$10.1M | -$11.4M | -$10.4M | -$7.6M | -$7.0M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -1197.3% | -3542.5% | -2072.0% | — | — | — |
| Net margin | -1196.6% | -3540.9% | -2094.9% | — | — | — |
| Line item | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$2.6M | -$2.9M | -$1.8M | -$2.0M | -$1.8M | -$1.5M | -$2.1M | -$1.9M |
| Net income | -$2.6M | -$2.8M | -$1.8M | -$6.3M | -$1.8M | -$1.5M | -$2.0M | -$1.9M |
| Diluted EPS | -$2.76 | -$16.11 | -$10.05 | -$56.85 | -$0.85 | -$3.74 | -$2.45 | -$3.57 |
| Operating cash flow | -$1.7M | -$2.2M | -$2.0M | -$1.7M | -$1.7M | -$1.7M | -$1.9M | -$1.8M |
| Free cash flow | -$1.7M | -$2.2M | -$2.0M | -$1.7M | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | — | — | — | — | — | — | — | — |
Company news
Jul 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Shah Chetan | Tax withholding | 2,182 | $0.82 | $1,789.24 | filing |
| 2026-06-30 | Gikakis Nicolas | Tax withholding | 2,182 | $0.82 | $1,789.24 | filing |
| 2026-06-30 | BROENNIMAN EDWARD G | Tax withholding | 1,091 | $0.82 | $894.62 | filing |
| 2026-04-17 | Rossetti Angela | Award | 21,815 | $2.29 | $49,956.35 | filing |
| 2026-04-17 | Shah Chetan | Award | 21,815 | $2.29 | $49,956.35 | filing |
| 2026-04-17 | BROENNIMAN EDWARD G | Award | 21,815 | $2.29 | $49,956.35 | filing |
| 2026-04-17 | Gikakis Nicolas | Award | 21,815 | $2.29 | $49,956.35 | filing |
| 2026-03-31 | Shah Chetan | Tax withholding | 178 | $2.19 | $389.82 | filing |
| 2026-03-31 | Gikakis Nicolas | Tax withholding | 178 | $2.19 | $389.82 | filing |
| 2026-03-31 | BROENNIMAN EDWARD G | Tax withholding | 89 | $2.19 | $194.91 | filing |
| 2025-12-31 | Gikakis Nicolas | Tax withholding | 179 | $2.77 | $495.83 | filing |
| 2025-12-31 | Shah Chetan | Tax withholding | 179 | $2.77 | $495.83 | filing |
| 2025-12-31 | BROENNIMAN EDWARD G | Tax withholding | 89 | $2.77 | $246.53 | filing |
| 2025-09-30 | Gikakis Nicolas | Tax withholding | 1,786 | $0.75 | $1,337.71 | filing |
| 2025-09-30 | Shah Chetan | Tax withholding | 1,786 | $0.75 | $1,337.71 | filing |
| 2025-09-30 | BROENNIMAN EDWARD G | Tax withholding | 893 | $0.75 | $668.86 | filing |
| 2025-06-30 | Gikakis Nicolas | Tax withholding | 1,786 | $1.20 | $2,143.20 | filing |
| 2025-06-30 | Shah Chetan | Tax withholding | 1,786 | $1.20 | $2,143.20 | filing |
| 2025-06-30 | BROENNIMAN EDWARD G | Tax withholding | 893 | $1.20 | $1,071.60 | filing |
Latest 19 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.